Dr. John Eisenbrey’s lab at Thomas Jefferson University focuses on improving imaging techniques for detecting recurrent cancers, particularly using contrast-enhanced ultrasound (CEUS). They aim to refine methods for assessing responses to treatments like renal cancer ablation and liver cancer chemoembolization. The lab's goal is to enhance the accuracy of these imaging technologies, making cancer detection and treatment assessment faster and more effective for patients.